Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Patients given phenytoin after an intracerebral hemorrhage (ICH) have more fevers while hospitalized and worse functional outcomes at 3 months, according to investigators…
NEW YORK (Reuters Health) – Intensive statin therapy is more effective than standard doses in reducing the risk of major adverse events after angioplasty for acute coronary syndromes…
NEW YORK (Reuters Health) – Continuing to take low-dose aspirin after endoscopic treatment of a bleeding peptic ulcer raises the risk for re-bleeding but may also reduce mortality…
NEW YORK (Reuters Health) – Giving intravenous drugs during out-of-hospital cardiac arrest does not improve survival, according to a study in the Journal of the American Medical Association…
NEW YORK (Reuters Health) – Adding cetuximab to standard chemotherapy for colorectal liver metastases often shrinks inoperable lesions enough to permit resection, according to a study released today…
NEW YORK (Reuters Health) – Treating HER-2 positive, metastatic breast cancer with trastuzumab significantly increased survival in a retrospective study, to the point were such women given the…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
Robert Shorr, Ph.D, D.I.C, CEO, Cornerstone Pharmaceuticals, discusses how physicians can understand a new oncology drug, starting with knowing its safety limitations. He also explains the structure and…
E. Murat Tuzcu, MD, Professor of Medicine, Cleveland Clinic, discusses the current limitations of catheter-based valve replacements, including problems with the femoral artery route and atherosclerosis and paravalvular…
NEW YORK (Reuters Health) – Chronic renal disease appears to reduce platelet responsiveness to clopidogrel, according to a Korean research team. Furthermore, increasing the dose of clopidogrel does…
